Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients Using Plerixafor

Trial Profile

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients Using Plerixafor

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Plerixafor (Primary)
  • Indications Sickle cell anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2021 Results reporting optimization of autologous hematopoietic progenitor stem cell apheresis collection from Plerixafor mobilized patients enrolled on two clinical trials (NCT03226691 and NCT04443907) presented at the 63rd American Society of Hematology Annual Meeting and Exposition
    • 06 Nov 2019 Results assessing efficacy and safety of plerixafor mobilization in patients with sickle cell disease, released at the 61st Annual Meeting and Exposition of the American Society of Hematology.
    • 28 Feb 2019 Status changed from recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top